Business
ABL Diagnostics Reports Historic 2025 Annual Results: Net Income Explosion (+246%), Strong Operating Profitability and Global Acceleration
WOIPPY, France, May 11, 2026--Regulatory News: ABL Diagnostics (Paris:ABLD)(Euronext Compartment B – ISIN: FR001400AHX6), a company specialized in in vitro diagnostics, today announces its annual results for the fiscal year ended December 31, 2025, approved by the Board of Directors during its meeting on April 30, 2026.
About this update from Abl Diagnostics Sa
[{"type":"list","items":[{"val":[{"type":"text","content":"Strong revenue growth of +30.4% to €6.95m","length":41,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Positive operating income of €290k, exceeding analyst forecasts","length":63,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Net income soaring to nearly €1m (€987k)","length":40,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"International business acceleration: 70% of revenue generated outside France, with a network expanded to 57 distributors across 50 countries","length":140,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"A year of major transformation with the integration of Fast Track Diagnostics (FTD) syndromic PCR tests, the Vela Diagnostics range, and the Institut Pasteur HPV RNA-Seq test","length":174,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":458,"olType":false},{"type":"text","content":"WOIPPY, France, May 11, 2026--(BUSINESS WIRE)--Regulatory News:","length":63,"tagName":"p"},{"type":"text","content":"ABL Diagnostics (Paris:ABLD)(Euronext Compartment B – ISIN: FR001400AHX6), a company specialized in in vitro diagnostics, today announces its annual results for the fiscal year ended December 31, 2025, approved by the Board of Directors during its meeting on April 30, 2026.","length":274,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;border-left:solid black 1.0pt;border-right:solid black 1.0pt;padding-left:0.0px;background-color:#D3D3D3;width:50%;","val":[{"type":"text","content":"Financial Indicator","length":19,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding-left:0.0px;background-color:#D3D3D3;width:15%;","val":[{"type":"text","content":"FY 2025","length":7,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align:top;border-top:solid black 1.0pt;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding-left:0.0px;background-color:#D3D3D3;width:15%;","val":[{"type":"text","content":"FY 2024","length":7,"tagName":"p","attribs":{}}]},{"colspan":"1","rowspan":"1","style":"vertical-align...